Average Co-Inventor Count = 3.60
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Curis, Inc. (46 from 141 patents)
2. Cytomed, Inc. (13 from 17 patents)
3. Ucb S.a. (9 from 119 patents)
4. Genentech, Inc. (2 from 3,237 patents)
5. Millennium Pharmaceuticals Limited (2 from 850 patents)
6. Leukosite, Inc. (1 from 5 patents)
7. Pharmaengine, Inc. (1 from 1 patent)
8. Guris, Inc. (1 from 1 patent)
73 patents:
1. 11654136 - Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
2. 11597732 - Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
3. 11560377 - Fused amino pyridine as HSP90 inhibitors
4. 11261195 - Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
5. 11135205 - Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
6. 11116767 - 3,5-disubstituted pyrazoles useful as checkpoint kinase 1 (Chk1) inhibitors, and their preparations and applications
7. 10894795 - Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
8. 10844056 - Fused amino pyridine as HSP90 inhibitors
9. 10676482 - Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
10. 10543197 - Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
11. 10428068 - Fused amino pyridine as HSP90 inhibitors
12. 10336770 - Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
13. 10214514 - Hedgehog antagonists having zinc binding moieties
14. 10111864 - Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
15. 10035797 - Fused amino pyridine as HSP90 inhibitors